AI assistant
Sanofi India Ltd — Regulatory Filings 2022
Oct 6, 2022
59270_rns_2022-10-06_99da5bcc-e614-454b-a266-37b2b6f951b3.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [107 x 29] intentionally omitted <==
03[rd] October 2022
The Secretary The Secretary, Bombay Stock Exchange Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor Dalal Street Plot No. C/1, G Block Mumbai 400 001 Bandra-Kurla Complex Bandra East Mumbai 400 050
Intimation regarding loss of share certificates
Dear Sirs
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are given below:
| Sr. No. | Name of Shareholder(s) | Certificate no. |
Distinctive numbers | No. of Shares |
|---|---|---|---|---|
| 1. | NALINKANT D SHETH | 19553 65195 |
8519231 - 8519280 21039423 - 21039472 |
100 |
Kindly take the above information on record.
Thanking you,
Yours faithfully
For Sanofi India Limited
Radhika Shah Company Secretary & Compliance Officer
Membership No.: 19308
Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number : L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: [email protected]